

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb40489</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Khanbabaei</surname><given-names>Hashem</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Abbasi</surname><given-names>Samaneh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fani</surname><given-names>Mona</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Soltani</surname><given-names>Saber</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Zandi</surname><given-names>Milad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Najafimemar</surname><given-names>Zahra</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ebrahimi</surname><given-names>Saeedeh</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>3</fpage>
      <lpage>9</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>6</month>
          <year>2021</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people&amp;#39;s life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
